The Biotech Investors Day brings together international biotech companies with international investors. It is a partnering event that provides new perspectives for international business opportunities. Early stage/pre-IPO, late-stage and public companies meet with leading investors, analysts, money managers and pharma licensing executives.
In two panels, experts will discuss the global biotech situation – looking at financial aspects (investors that actively invest in Biotech, exit channels, exchanges) and “hot technologies” that are a magnet for further investment.
German companies such as BioNTech successfully raised $270 million in one of the largest financing rounds in Europe. IPO rumors have been rampant in the market for months. InflaRx succeeded with its IPO on the NASDAQ last year, Asian money from Staidson Hongkong Investment helped in a series C financing.
Who will be the next successful candidate? What are investors looking for?
The event will be in English and cover not only medical fields but will also address the bioeconomy and enabling technology companies.